| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Tempest Therapeutics (NASDAQ:TPST) through any online brokerage.
Other companies in Tempest Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Tempest Therapeutics has a consensus price target of $27.00.
The stock price for Tempest Therapeutics (NASDAQ: TPST) is $0.628914 last updated October 16, 2026 at 4:06 PM EDT.
There are no upcoming dividends for Tempest Therapeutics.
Tempest Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Tempest Therapeutics.
Tempest Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
